Impaired reactivity to mental stress in premenstrual dysphoric disorder (PMDD) patients

Nakamoto, Yurie; Sato, Mitsuko; Miwa, Masako; Murakami, Masato; Yoshii, Mitsunobu

doi:10.1016/j.neures.2007.06.689

Cited by 2 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Due to the experience of traumatic or stressful events, symptomatic women may have an impaired stress response; 27,52 women with PMDD are thus more likely than controls to have histories of abuse. 53 …”

Section: Diagnosismentioning

confidence: 99%

Update on Research and Treatment of Premenstrual Dysphoric Disorder

Cunningham

Yonkers

O’Brien

et al. 2009

Harvard Review of Psychiatry

153

114

View full text Add to dashboard Cite

Many women in their reproductive years experience some mood, behavioral. or physical symptoms in the week prior to menses. Variability exists in the level of symptom burden in that some women experience mild symptoms, whereas a small minority experience severe and debilitating symptoms. For an estimated 5%–8% of premenopausal women, work or social functioning are affected by severe premenstrual syndrome. Many women in this group meet diagnostic criteria for premenstrual dysphoric disorder (PMDD). Among women who suffer from PMDD, mood and behavioral symptoms such as irritability, depressed mood, tension, and labile mood dominate. Somatic complaints, including breast tenderness and bloating, also can prove disruptive to women's overall functioning and quality of life. Recent evidence suggests that individual sensitivity to cyclical variations in levels of gonadal hormones may predispose certain women to experience these mood, behavioral, and somatic symptoms. Treatments include: antidepressants of the serotonin reuptake inhibitor class, taken intermittently or throughout the menstrual cycle; medications that suppress ovarian cyclicity; and newer oral contraceptives with novel progestins. (Harv Rev Psychiatry 2009;17:120–137.)

show abstract

Section: Diagnosismentioning

confidence: 99%

Update on Research and Treatment of Premenstrual Dysphoric Disorder

Cunningham

Yonkers

O’Brien

et al. 2009

Harvard Review of Psychiatry

153

114

View full text Add to dashboard Cite

show abstract

“…PMDD women also report more traumatic life stress, including sexual and physical abuse [21,25]. Due to stressful or traumatic events, women may have an impaired stress response, being PMDD women more vulnerable [24,26,27].…”

Section: Prevalencementioning

confidence: 99%

Premenstrual Syndrome and Premenstrual Dysphoric Disorder: Symptoms and Cluster Influences

Pérez‐López¹,

Chedraui²,

Pérez-Roncero³

et al. 2009

TOPJ

View full text Add to dashboard Cite

Many women in their reproductive years experience some mood, behavioral, or physical symptoms in the week prior to menses. Women experiencing mild symptoms may have a wide variability in the level of symptom burden, whereas a minority suffers severe and debilitating symptoms. Severe premenstrual syndrome (PMS) affects 3% to 5% of women of reproductive age and has been classified under the Diagnostic and Statistical Manual of Mental Disorders (DSM IV) as premenstrual dysphoric disorder (PMDD). Both disorders are characterized mainly by symptoms confined to the premenstrual period, which reduce not only patients' quality of life, but also their working activities. Women suffering PMDD experience severe dysphoric mood, and a greater desire and actual intake of certain foods, demonstrating impaired cognitive performance during the luteal phase. Several theories have been proposed to explain the underlying mechanisms of PMS and PMDD with complex bio-psycho-social factors involved. Although precise causes are unknown, the late luteal phase could be associated with diverse psychosomatic and behavioral symptoms appearing premenstrually which should be appropriately treated. Notwithstanding this high prevalence, no specific symptoms or signs appear, nor have any recognizable anatomical factors been identified in women suffering PMS or PMDD, and hence, no universal treatment yet exists. Despite this, therapeutic progress has been reached, although the ideal treatment has not yet been obtained due to the many clusters involved.

show abstract

Impaired reactivity to mental stress in premenstrual dysphoric disorder (PMDD) patients

Cited by 2 publications

References 0 publications

Update on Research and Treatment of Premenstrual Dysphoric Disorder

Update on Research and Treatment of Premenstrual Dysphoric Disorder

Premenstrual Syndrome and Premenstrual Dysphoric Disorder: Symptoms and Cluster Influences

Contact Info

Product

Resources

About